Filing Flows › Pacific Biosciences of California (PACB) › Q3 2026 › vs Q3 2025
Pacific Biosciences of California (PACB) Q3 2026 vs Q3 2025 (year over year)
Pacific Biosciences of California's revenue rose $2.1M (+6%) from $38.4M in Q3 2025 to $40.6M in Q3 2026. The biggest changes: Product revenue +$1.4M (+4%); Service and other revenue +$718K (+12%).
Pacific Biosciences of California, Q3 2026: revenue $40.6M (+6% year over year), operating margin -91.2%, net loss $37.8M, operating cash flow −$37.6M. The chart draws each line against Q3 2025, the increases inside each band.
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Consumables revenue | $20.8M | $21.3M | −$456K | -2% |
| Instrument revenue | $13.2M | $11.3M | $1.9M | +16% |
| Product revenue | $34.0M | $32.6M | $1.4M | +4% |
| Service and other revenue | $6.6M | $5.8M | $718K | +12% |
| Revenue | $40.6M | $38.4M | $2.1M | +6% |
| Net loss | $37.8M | $38.0M | −$154K | -0.4% |
| Costs & expenses | $78.4M | $77.7M | $709K | +0.9% |
| Operating costs | $77.6M | $77.3M | $248K | +0.3% |
| Interest & other, net | $575K | −$1.3M | $1.8M | — |
| Income tax | $269K | $383K | −$114K | -30% |
| Cost of revenue | $27.1M | $22.5M | $4.6M | +20% |
| Research & development | $20.2M | $22.8M | −$2.6M | -11% |
| SG&A | $29.4M | $31.1M | −$1.7M | -5% |
| Other operating costs | $833K | $833K | $0 | 0% |
| Operating cash sources | $48.6M | $33.2M | $15.4M | +47% |
| Depreciation | $2.5M | $3.5M | −$1.0M | -29% |
| Share-based compensation | $8.5M | $11.0M | −$2.4M | -22% |
| Cash used in operations | $37.6M | $18.7M | $18.9M | +101% |
| Net loss absorbed | $37.8M | $38.0M | −$154K | -0.4% |
| Working capital & other | $10.8M | −$4.8M | $15.6M | — |
Questions
How much did Pacific Biosciences of California's revenue grow year over year in Q3 2026?
Pacific Biosciences of California's revenue rose $2.1M (+6%) from $38.4M in Q3 2025 to $40.6M in Q3 2026.
What drove Pacific Biosciences of California's revenue change in Q3 2026?
Product revenue +$1.4M (+4%); Service and other revenue +$718K (+12%).